INTRODUCTION
In the gastrointestinal (GI) tract, phasic contractions and more integrated, whole-organ motility behaviors, such as gastric peristalsis and intestinal segmentation, depend upon pacemaker activity generated by interstitial cells of Cajal (ICC) (1) (2) (3) (4) . Pacemaker events generate electrical slow waves that propagate through networks of electrically coupled ICC and conduct to smooth muscle cells (SMCs) to initiate Ca 2+ entry through L-type Ca 2+ channels and excitationcontraction coupling (3) . Slow waves depend on the activation of Ca 2+ -activated Cl − channels (CaCCs) (Ano1) and T-type Ca 2+ channels (5) (6) (7) (8) . From sites of pacemaker initiation, slow waves propagate through networks of ICC by means of voltage-dependent Ca 2+ entry and amplification of [Ca 2+ ] i by Ca 2+ -induced Ca 2+ release from ryanodine and inositol 1,4,5-trisphosphate (IP 3 ) receptors (9) . Ca 2+ release events couple to activation of Ano1 channels. Thus, Ca 2+ handling mechanisms in ICC are fundamental to GI motility.
Because of its important role in motility, Ca 2+ signaling in ICC must be tightly regulated. As in other cells (10) , small excluded volumes (nanodomains) created by close associations (≈20 nm) between the endoplasmic reticulum (ER) and the plasma membrane appear to be crucial structures that enable pacemaker activity. Because of their small volumes, the dynamic range of Ca 2+ and other ion concentrations may be far greater in nanodomains than in the cytoplasm at large. The ER has a finite capacity to store Ca 2+ , so frequent release of Ca 2+ from ER stores, as observed in ICC (9, 11) , requires a mechanism to replenish the stores. This occurs, in part, by reuptake of Ca 2+ through SERCA [sarco/endoplasmic reticulum Ca 2+ ATPase (adenosine triphosphatase)] that regulates the Ca 2+ concentration in the ER (12) , but SERCA pumps compete with extrusion mechanisms, such as Na + /Ca 2+ exchange and the plasma membrane Ca 2+ ATPases, such that, over time, net loss of stored Ca 2+ occurs without a refilling mechanism (13) . A mechanism linked to store refilling is store-operated Ca 2+ entry (SOCE). Passive emptying of ER Ca 2+ by treatment with SERCA inhibitors results in Ca 2+ influx (14) (15) (16) . The ER transmembrane Ca 2+ sensing molecule known as STIM (stromal interacting molecule) and the Ca 2+ -selective plasma membrane ion channel Orai provide the central mechanism for ER Ca 2+ refilling (17) (18) (19) (20) (21) . Mouse and human genomes contain two STIM paralogs (STIM1 and STIM2) and three Orai paralogs (ORAI1 to ORAI3). Emptying of stores causes rearrangement and oligomerization of STIMs, which translocate within the ER membrane such that the C-terminal cytoplasmic fragments of STIM bind to Orai. STIM association opens and increases the Ca 2+ selectivity of Orai (22, 23) . In most cells, formation of this SOCE junctional assembly is slow (10 to 30 s), but in skeletal muscles, SOCE occurs with much faster kinetics than in nonexcitable cells because of either preassembly of STIM1-Orai1 complexes without store depletion (24) or the expression of a specialized splice variant of STIM1 that can respond to store depletion and form junctional complexes with Orai within 1 s (25) . We investigated the role of SOCE in sustaining pacemaker activity of ICC of the murine small intestine. ER stores release Ca 2+ during slow waves (9) and have only about 1 s to reset before the next slow wave cycle. We identified multiple STIM and Orai paralogs in ICC. Blocking the STIM-Orai complex with an antagonist or a peptide that disrupts STIM-Orai binding resulted in rundown of pacemaker activity, suggesting a key role for SOCE in the pacemaker activity of the GI tract.
the expression of Orai1, Orai2, Orai3, Stim1, and Stim2 transcripts in extracts of enzymatically dispersed cells from the tunica muscularis of the small intestine (which consisted of unsorted cells) and in FACSsorted, purified ICC. All paralogs of Orai and Stim were expressed in ICC, and Orai1, Orai2, Orai3, and Stim2 displayed increased expression in ICC compared to unsorted cells (fig. S1, A and B). (Fig. 1A) . To identify the inward current, ramp protocols (400-ms ramps from −80 to 80 mV) were applied before and in the presence of 2 mM [Ca 2+ ] o . The inward current (Fig. 1B) ] o solution, failed to induce inward current at the holding potential (Fig. 1, C and D) . These data suggest that, if SOCE is functional in SMCs, the current generated is very small. Increasing [Ca 2+ ] o to 2 mM increased inward current in store-depleted ICC but not in SMCs (Fig. 1E) .
Activation of a Cl

Block of SOCE currents in HEK 293 cells and ICC by an inhibitory STIM1 peptide
Selective pharmacological inhibitors of STIM1 are not available. Therefore, we developed novel peptides designed to act as dominantnegative inhibitors to interrupt STIM1 activity. These peptides target a cytosolic domain responsible for functional interactions with Orai channels in the plasma membrane. We identified a 27-residue amino acid sequence within the STIM-Orai activation region (SOAR) that forms the second cytoplasmic coiled-coil domain (CC2) peptide of STIM1. Patch clamp experiments were performed on human embryonic kidney (HEK) 293 cells stably expressing Orai1 and Stim1 (26) to determine the effects of this peptide on I CRAC . Cells were treated with thapsigargin and 0 mM [Ca 2+ ] o to passively deplete ER Ca 2+ stores and the CaCC antagonist 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB) to block Cl − current. The CC2 peptide or scrambled CC2 peptide was added to pipette solutions and dialyzed into cells held at −50 mV ( Fig. 2A) . In cells treated with the scrambled CC2 peptide, increasing [Ca 2+ ] o from 0 to 2 mM caused development of inward current, a 10.4-fold increase at −80 mV (Fig. 2B) . In cells treated with the CC2 peptide, the inward current resulting from restoration of 2 mM [Ca 2+ ] o was reduced by 2.8-fold (Fig. 2, C and D) . In comparison to the scrambled CC2 peptide, the CC2 peptide decreased the inward current induced by 2 mM [Ca 2+ ] o by 6.9-fold at −80 mV (Fig. 2E ). These data demonstrate that the CC2 peptide (Fig. 2F) Table 1 . The composition of pipette solutions and bath solutions for patch clamp. Solutions I, II, and VII were adjusted to pH 7.4 with tris, and solutions III, IV, V, VI, and VIII were adjusted to pH 7.2 with tris. BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; ATP, adenosine 5′-triphosphate. ] o to 2 mM induced inward current (Fig. 3A) . Ramp potentials (from −80 to +80 mV) were applied before and after adding [Ca 2+ ] o to determine the current-voltage characteristics of I CRAC . [Ca 2+ ] o (2 mM) induced I CRAC -like currents (Fig. 3B ), increasing inward current by 2.6-fold at −80 mV. The reversal potential of the current responses to ramp potentials shifted from 0.4 ± 1.8 mV to 19.8 ± 3.3 mV, consistent with the conductance activated by 2 mM [Ca 2+ ] o being permeable to Ca 2+ (Fig. 3B) . In cells dialyzed with the CC2 peptide,
Solutions
] o to 2 mM did not induce appreciable inward current at −80 mV (Fig. 3, C and D ] o to 2 mM induced inward current. 2-APB (10 M) enhanced the inward current, whereas 100 M 2-APB inhibited the current (Fig. 5A ). Ramp potentials (−80 to +80 mV) were applied during the experiments to quantify I CRAC (Fig. 5B) . The I CRAC -like current increased by fivefold at −80 mV after restoring [Ca 2+ ] o to 2 mM. 2-APB at 10 M enhanced I CRAC -like current by 1.5-fold, and 2-APB at 100 M decreased the current by 5-fold (Fig. 5C ). (Fig. 6A) . Ramp potentials applied during whole-cell recording showed that IP 3 increased inward currents by ] o at 0 mV in ICC and SMCs. Data are means ± SEM (n = 5 cells for each group; **P < 0.01, ***P < 0.001, Student's two-tailed t test).
Activation of
4.6-fold and that GSK-7975A reduced inward current by 4.7-fold at −80 mV (Fig. 6 , B and C).
Reduced STICs and slow wave currents in ICC by the STIM1 inhibitory peptide
To investigate the effects of SOCE on spontaneous transient inward currents (STICs) and slow wave currents in ICC (8, 30) , voltageclamp experiments on cells held at −80 mV were performed using a Cs + -rich pipette solution to prevent contamination from K + conductances. Under these conditions, ongoing STICs were recorded and slow wave currents were initiated by step depolarization from −80 to −35 mV (8) . When ICC were dialyzed with the CC2 peptide, the frequency of STICs was reduced by 4-fold, and amplitude decreased by 4.7-fold (Fig. 7A) . Peak slow wave current was also reduced by fourfold by CC2 peptide dialysis (Fig. 7B) . Dialysis of the scrambled CC2 peptide into a different group of cells did not affect slow wave currents or the frequency or amplitude of STICs (Fig. 7 , C to G). CC2 peptide, but not scrambled CC2 peptide, reduced the amplitude of STICs as a function of dialysis time ( 
Reduction in Ca
2+ transients in small intestinal ICC by GSK-7975A In ICC, STICs are caused by the activation of CaCC (30) , and Ca 2+ release events appear to be the source of Ca 2+ for activation of CaCC (9, 11) . Recordings of pacemaker ICC in the plane of the myenteric plexus (ICC-MY) in situ ( Fig. 9A ) revealed a pattern of rhythmic Ca 2+ transients throughout the ICC-MY network. Firing of Ca 2+ transients consisted of temporal clusters of ~1-s duration from multiple firing sites within each field of view (FOV), which are termed Ca 2+ transient clusters (CTCs) (9) . Analysis of Ca 2+ events in ICC-MY was performed with an accumulation map of all Ca 2+ transient particles (PTCLs) recorded during a 20-s period from one FOV, displayed as a heat map. When GSK-7975A was added, CTCs were greatly diminished, as shown by the PTCL accumulation map (Fig. 9 , B and C). All firing sites in an FOV were also displayed as an occurrence map in which each firing site in the FOV was color-coded and shown as a "lane," and the PTCL area and count for Ca 2+ events were plotted below the occurrence map (Fig. 9D) . GSK-7975A reduced the number of firing sites, the PTCL area, and count of Ca 2+ events within the same FOV (Fig. 9E) . Ca 2+ firing sites were reduced by 10.6-fold by GSK-7975A treatment (Fig. 10A) , and the regular temporal clustering of Ca 2+ transients was reduced. The probability that an individual Ca 2+ firing site would generate a Ca 2+ transient during a CTC was reduced by 31.9-fold after addition of GSK-7975A (Fig. 10B) . The overall frequency of CTCs was also reduced by 2.5-fold (Fig. 10C) . Furthermore, the PTCL area was reduced by 117-fold (Fig. 10D) , and the PTCL count/frame was reduced by 56-fold after GSK-7975A treatment (Fig. 10E) .
DISCUSSION
ICC display dynamic Ca
2+ signaling characterized by localized Ca 2+ transients that activate CaCC in the plasma membrane (8, 9, 11, 31) . Ca 2+ signaling is fundamental to pacemaker activity of ICC and is also likely to play an important role in neurotransmission in ICC. We investigated how SOCE, mediated by STIM-Orai interactions, is involved in sustaining Ca 2+ transients and STICs in ICC of the murine small intestine. ICC expressed the two components of the molecular apparatus required for SOCE (STIM and Orai), and SOCE currents were apparent in isolated and identified ICC. Activation of SOCE enhanced CaCC, but when this conductance was blocked, small amplitude inward currents, consistent with I CRAC , were measured in ICC. A dominant-negative peptide, designed to inhibit STIM-Orai binding, blocked I CRAC in HEK 293 cells expressing Orai1 and STIM1 and in ICC. The same peptide blocked STICs and slow wave currents in ICC. The Orai antagonist GSK-7975A had similar effects on I CRAC and STICs in ICC, and it also blocked Ca 2+ transients in ICC networks in intact muscles. Together, these observations demonstrate that SOCE assists in maintenance of the Ca 2+ stores required for pacemaker activity in ICC.
STIM and Orai mediate SOCE in nonexcitable cells (32) and in some excitable cells, such as skeletal muscle cells (33, 34) . Because of the relatively slow kinetics of STIM1-Orai1 interactions, SOCE is unlikely to contribute to cytoplasmic Ca 2+ during twitch responses. It is more likely that this mechanism contributes to longer-term maintenance of store Ca 2+ or participates in other cell signaling mechanisms (35) . Cardiac and smooth muscle cells also express STIM and Orai genes (35, 36) ; however, lower expression levels suggest functions for SOCE other than regulation of contraction (37, 38) . In cultured intestinal ICC, STIM1 overexpression increases pacemaker potentials, and overexpression of the SOCE inhibitor SARAF (40) suppresses pacemaker activity (41) . The present study further explored the presence and importance of SOCE in pacemaker activity of ICC. I CRAC was measured directly in freshly dispersed ICC. STICs and STDs, which are fundamental for generation of pacemaker activity in ICC (6, 8, 42) , were inhibited by an Orai antagonist and by a dominant-negative peptide. The Orai antagonist also inhibited the Ca 2+ transients that underlie pacemaker activity in ICC (9) . The role of SOCE in pacemaker activity might be questioned on the basis of kinetics. The frequency of electrical slow waves in murine small intestinal ICC is about 30 cycles per minute, depending upon experimental conditions (9) . The duration of the slow wave event is about 1 s from the onset of depolarization (upstroke phase) to completion of the plateau phase (9) . Ca 2+ transients occur asynchronously throughout the plateau phase to sustain the activation of CaCC, and depolarization to approximately E Cl is maintained during the plateau (9, 43) . At the depolarized potential of the plateau (≈−10 mV), the driving force for Ca 2+ entry [difference between reversal potential for I CRAC (E CRAC ) and membrane potential at the peak of the plateau phase (E Plat )] is relatively small, so the period between slow waves is likely to be the period of greatest SOCE. Thus, under normal circumstances, Ca 2+ stores have about 1 s to refill after each slow wave. The rate of activation of SOCE in nonexcitable cells is slow, requiring tens of seconds for full activation (44) . These characteristics are too slow to maintain stores that release Ca 2+ every few seconds. In skeletal muscles, the kinetics of STIM-Orai due to Ca 2+ depletion are faster because of a specialized splice variant or sustained coupling of the complex (25, 45, 46) . RNA sequencing analysis of ICC from small intestinal muscles shows that several splice variants of STIM1 are expressed in these cells (47) . Although the skeletal muscle isoform was not detected, other splice variants of STIM may convey kinetic properties suitable for the maintenance of pacemaker activity.
When expressed with STIM proteins, the three homologs of Orai can reconstitute SOCE or CRAC currents (I CRAC ). CRAC channels can be composed of singleor multiple-type homologs of Orai (48) . Transcripts of all three Orai homologs of Orai were more abundant in ICC than in unsorted cells. ICC expressed Stim1 at relatively higher levels than Stim2 ( fig. S1B) , and Stim1 was expressed at relatively higher levels than Stim2. STIM1 and STIM2 both translocate to the plasma membrane-ER junctions and facilitate development of I CRAC upon store depletion (49 ] to below 200 M (50, 51) . Thus, expression of these two isoforms in ICC may have consequences for maintenance of basal ER Ca 2+ levels (in preparation for pacemaker events) and storedepleting Ca 2+ release events (recovery from post-pacemaker activity). It is difficult to establish the functional influence of STIM-Orai activity in physiological settings because selective pharmacological inhibitors of STIM are not available, and global knockout animals are not viable (52) . Acute knockdown has been used effectively in cultured cells, but this approach would be problematic for studies of ICC because the pacemaker mechanism changes substantially in culture (53) . Conditional knockouts are also problematic because of the multiple STIM and Orai isoforms ( fig. S1, A and B) and because of incomplete gene deactivation with inducible Cre recombinase (42) . To overcome these obstacles, we developed a new strategy using an inhibitory peptide that is homologous to CC2 within the SOAR of the mouse STIM1 gene. Site-directed mutagenesis studies have shown that this region is critical for physical interactions between STIM1 and Orai channels and initiation of SOCE (54) . This peptide displays only limited homology with STIM2 (20 of 27 residues) and may selectively inhibit STIM1 activity, but this effect has not been confirmed experimentally. The inhibitory peptide abolished whole-cell CRAC channels in HEK cells expressing STIM1 and Orai1. We believe that by acting in a dominant-negative manner, the peptide prevents STIM1 binding to Orai1, thereby inactivating SOCE. The inhibitory peptide also blocked I CRAC , STICs, and slow wave currents in ICC, providing evidence for involvement of STIM1/Orai binding in pacemaker activity.
Early studies on SOCE (called CRAC channels in many papers) suggested that canonical transient receptor potential channels (TRPCs) are involved in SOCE because of enhanced responses in cells ectopically expressing TRPCs (55) (56) (57) . Although this topic is controversial, it should be noted that ICC of the small intestine express Trpc1 and other Trpc genes to a lesser extent (47) . Our results, which do not exclude interactions of TRPC1 with Orai, are compatible with the idea that STIM-Orai interactions are sufficient to sustain pacemaker currents and underlying Ca 2+ transients because the CC2 peptide blocked I CRAC and pacemaker currents.
Limitations of the current study include the expression of multiple paralogs of Orai and Stim in ICC, making it difficult to validate pharmacological findings by gene knockout studies. Interactions between STIM and Orai need to be rapid to accomplish store recovery between slow wave events. This might be accomplished by specialized splice variants of Stim genes, and several splice variants are present ] o . There are also several auxiliary proteins that modulate STIM-Orai interactions. Genes encoding many of these auxiliary proteins are expressed in ICC (47) , and future studies will need to be performed to understand their role in modulating pacemaker activity. Furthermore, additional mechanisms may contribute to store maintenance in ICC, and these have not yet been evaluated in a manner that allows a complete description of Ca 2+ handling during pacemaker activity. For example, slow waves require activation of voltage-dependent Ca 2+ channels to sustain propagation (7, 9) , and, as in SMCs, store refilling may be accomplished, in part, by Ca 2+ entry through this pathway (58) . Additional mechanisms, such as Na + /Ca 2+ exchange working in reverse mode, may also contribute to store replenishment.
In summary, SOCE appears to be critical for maintenance of pacemaker activity in ICC because we observed rapid loss of Ca 2+ release events and STICs, the fundamental steps in initiation and propagation of pacemaker activity in ICC, when SOCE was blocked. How STIMOrai function at a rate appropriate to the 30 cycle per minute frequency of slow waves in intestinal ICC, whether by continuous association or by the expression of STIM isoforms that facilitate rapid STIM-Orai binding and activation of Ca 2+ entry, are questions yet to be answered.
MATERIALS AND METHODS
Animals
C57BL/6 (Charles River Laboratories) and Kit copGFP/+ mice, as described previously (8) ) were a gift from D. Saur (Technical University of Munich, Munich, Germany). From crosses of these mice, Kit-CreGCaMP3 mice were generated, and Cre recombinase activation, along with subsequent GCaMP3 expression, was induced by injection with tamoxifen at 6 to 8 weeks of age (2 mg for three consecutive days), as described previously (9, 11) . Animals were used for experiments 50 days after tamoxifen injections. Animals were anesthetized with isoflurane (Aerrane, Baxter) before decapitation, and the small intestines were removed. The institutional Animal Use and Care Committee at the University of Nevada approved all procedures used in the breeding and sacrificing of animals.
Isolation of ICC and preparation of HEK 293 cells ICC were isolated from Kit
+/copGFP mice, as described previously (8) . Briefly, jejunal muscles were cut into small pieces, put in Ca , BD Falcon) in 35-mm culture dishes. The cells were allowed to stick to the coverslips, which required at least 3 hours of incubation at 37°C (atmosphere, 95% O 2 -5% CO 2 ) in culture medium (Clonetics) supplemented with 1% antibiotic-antimycotic (Gibco) and stem cell factor (5 ng ml −1 , Sigma-Aldrich). SMCs were isolated from the jejunum using similar techniques; however, the enzyme solution used to disperse SMCs contained (per milliliter) collagenase (4 mg, Worthington type II), bovine serum albumin (8 mg), trypsin inhibitor (8 mg), papain (1 mg), and l-dithiothreitol (0.15 mg, Sigma-Aldrich) for about 25 min. SMCs were stored in Ca 2+ -free Hanks' solution on ice for less than 6 hours before using for experiments.
HEK 293 cells stably expressing Orai1-V102C-CFP (cyan fluorescent protein) and STIM1-YFP (yellow fluorescent protein) were donated by D. Gill (The Pennsylvania State University College of Medicine, Hershey, PA). The generation of cell lines and the electrophysiological properties of the currents were described previously (26) . HEK 293 cells with stable expression of Ca v 3.2 (T-type Ca 2+ channels) were provided by E. Perez-Reyes (University of Virginia). Generation of cell lines and cell cultures was described previously (59) . HEK 293 cells were generated with expression of the Ano1 AC splice variant tagged with green fluorescent protein (GFP), as described previously (60) . HEK 293 cells were maintained in Dulbecco's modified Eagle's medium (Mediatech) supplemented with 10% fetal bovine serum (FBS), penicillin, and streptomycin. The Bio-Rad Gene Pulser Xcell System was used to perform all the plasmid transfections via electroporation in Opti-MEM medium. Transfected cells were cultured on coverslips in Opti-MEM with 5% FBS. ) (D), and CTC PTCL count (E) observed in control conditions (black bar) and after addition of GSK-7975A (10 M, red bar). Data are means ± SEM (n = 6 animals for each group; **P < 0.01, ***P < 0.001, Student's two-tailed t test).
Electrophysiological recording
patch-clamp amplifier (Axon Instruments) and digitized with a 16-bit analog to digital converter (Digidata 1440A, Axon Instruments) and stored using pCLAMP software (version 10.2, Axon Instruments). Data were sampled at 4 kHz and filtered at 2 kHz using an eight-pole Bessel filter for whole-cell experiments. The amplitude and frequency of STICs were analyzed using a threshold search (0.5 pA) in Event Detection of Clampfit (see Fig. 7A, inset; -free external solution; see solutions I and II, Table 1 ). The pipette solutions (solutions III, IV, V, and VI) for these experiments were described in Table 1 . Thapsigargin, NPPB, IP 3 , and 2-APB were purchased from Sigma-Aldrich. CPA was purchased from Tocris Bioscience. 2,6-Difluoro-N-(1-(4-hydroxy-1-(trifluoromethyl)benzyl)-1H-pyrazol-3-yl)benzamide (GSK-7975A) was purchased from Aobious. Stock solutions were made by dissolving NPPB, CPA, thapsigargin, and GSK-7975A in dimethyl sulfoxide (DMSO), and IP 3 was dissolved in water. Then, these chemicals were diluted in the bath solution to the specific concentrations. Final concentrations of DMSO were <0.1%.
The CC2 peptide and scrambled CC2 peptide were synthesized by NEO BioScience. The sequences for CC2 peptide and scrambled CC2 peptide are provided in Fig. 2F . CC2 peptide and scrambled CC2 peptide were dissolved in pipette solutions (solution IV or VI) for cell dialysis, and final concentrations were 10 M.
Cell purification and qPCR ICC from Kit copGFP/+ mice were purified by FACS (Becton Dickinson FACSAria) using 488-nm excitation and a 530/30-nm bandpass filter for GFP, as previously described (61) . Total RNA was isolated from ICC, and the mixed cell population was obtained after dispersion (pre-unsorted cells) from three mice (n = 3) using illustra RNAspin Mini RNA Isolation kit (GE Healthcare). Concentration and purity of RNA were measured using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific). Comparative amounts of RNA were used for first-strand complementary DNA (cDNA) and synthesized using SuperScript III (Invitrogen), according to the manufacturer's instructions. Polymerase chain reaction (PCR) was performed with specific primers using the AmpliTaq Gold PCR Master Mix (Applied Biosystems). The following numbers given in parentheses for the reference nucleotide sequence were used: Gapdh (NM_008084), Orai1 (NM_175423), Orai2 (NM_178751), Orai3 (NM_198424), Stim1 (NM_009287), and Stim2 (NM001081103). PCR products were analyzed on 2% agarose gels and visualized by ethidium bromide. Quantitative PCR (qPCR) was performed with the same primers used for PCR using SYBR Green Chemistry on the 7900HT RealTime PCR System (Applied Biosystems). cDNA was prepared from three mice (n = 3), and each cDNA was tested independently with triplicate replicates. Negative (no template) controls were included in each qPCR run. Melting curve analysis was performed using the manufacturer's standard protocol with no evidence for primer dimer or nonspecific products. Regression analysis using the serial 10-fold dilutions of cDNA was used to generate standard curves. Unknown amounts of mRNA were plotted relative to the standard curve for each set of primers and plotted graphically with Microsoft Excel. This gave transcriptional quantification of each gene relative to the endogenous Gapdh standard after log transformation of the corresponding raw data. In pilot studies, Gapdh was tested on ICC cells used in the present study and found to be an appropriate control for qPCR. Normalized values and SDs were calculated for differences of relative gene expression from four dilutions of technical duplicates from each animal.
Calcium imaging
After removal of the small intestines from Kit-Cre-GCaMP3 mice, the intestines were opened along the mesenteric border, and the mucosal layers were removed. Segments of jejunum (2 cm) were pinned flat in a Sylgard coated dish (serosa facing upward). Muscles were perfused continuously with KRB solution at 37°C and allowed to equilibrate for 1 hour. Images were acquired using an Eclipse E600FN microscope (Nikon Inc.) with a 60× 1.0 numerical aperture CFI Fluor lens (Nikon instruments Inc.). GCaMP3 was excited at 488 nm (Polychrome IV, TILL Photonics). After acquisition, movie sequences of Ca 2+ imaging data were imported into custom-written software (Volumetry G8d, GWH) for post hoc analysis. Ca 2+ imaging experiments were performed in the presence of 100 nM nicardipine to minimize movement artifacts resulting from tissue contractions and associated loss of focus. Ca 2+ transients observed in ICC-MY were quantified using particle analysis, as described previously (9) . Briefly, movies were imported into Volumetry G8d and processed to minimize residual motion artifacts. A differential (t = ±66 to 70 ms) and Gaussian filter (1.5 m × 1.5 m; SD, 1.0) was applied to better distinguish Ca 2+ transients from background. A particle analysis routine was applied to movies by use of a flood-fill algorithm that marked the structure of all adjoining pixels that had intensities above threshold. Ca 2+ transient particles (PTCLs) were brighter and larger than noise particles. The point at which noise particles emerged and reduced the average particle size was thresholded, and PTCLs above this threshold were then saved as a coordinate-based PTCL movie. Residual noise in the PTCL file was filtered out by only including PTCLs > 6 m 2 (diameter, ~2 m or smaller) in analysis. Ca 2+ transients in ICC-MY manifested as temporal clusters from multiple sites within the FOV, and these temporally clustered events were defined as CTC (9) . CTCs were defined as periods of time in which Ca 2+ transients were separated by less than 300 ms. In a 30-s recording, 1000 frames were acquired per experiment. The probability (%) that a Ca 2+ firing site in the FOV fired during a CTC, along with PTCL area (in square micrometers) and total PTCL count for the entire recording, was calculated. These data were expressed as PTCL area/frame and PTCL count/frame.
Statistical analyses
Molecular data are expressed as means ± SDs, and all other data are expressed as means ± SEM of n cells. All statistical analyses were performed using GraphPad Prism. We used Student's t test and ANOVA, followed by Bonferroni's multiple comparisons test to compare two groups and more than two groups, respectively. In all statistical analyses, P < 0.05 was considered statistically significant.
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www.sciencesignaling.org/cgi/content/full/11/534/eaaq0918/DC1 Fig. S1 . Expression of Orai and Stim paralogs in ICC of the small intestine. Fig. S2 . CC2 peptide has no effect on HEK 293 cells expressing Orai1 and Stim1 without thapsigargin pretreatment. Fig. S3 . Cav3.2 current and Ano1 current are not significantly affected by GSK-7975A. Fig. S4 . Effect of CC2 peptide on Ano1 current.
